SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-016574
Filing Date
2022-06-13
Accepted
2022-06-13 16:36:25
Documents
13
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49560
  Complete submission text file 0001493152-22-016574.txt   270458

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20220609.xsd EX-101.SCH 3682
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20220609_def.xml EX-101.DEF 27023
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20220609_lab.xml EX-101.LAB 37280
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20220609_pre.xml EX-101.PRE 25644
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5542
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221012128
SIC: 2834 Pharmaceutical Preparations